🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will be conducted among 1530 healthy infants of 9 to 12 months o...
Status
Not Yet Recruiting
Location
Icddr,B
Start Date
2025-04-01
Trial ID
NCT06815835
The aim of the current clinical study was to evaluate, for the first time i...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-10-06
Trial ID
NCT05073003
Japanese encephalitis (JE) is the leading cause of viral neurological disea...
Status
Completed
Location
Hebei Provincial Center for Disease Control and Prevention
Start Date
2015-08
Trial ID
NCT02643433
Treatments Being Tested
Measles and rubella are highly contagious acute viral diseases. As per WHO,...
Status
Completed
Location
Unidade de Ensaios Clínicos para Imunobiológicos
Start Date
2015-09
Trial ID
NCT02196285
Treatments Being Tested
This is a phase 1/2, single-centre, double-blind, double-dummy, randomized,...
Status
Completed
Location
Medical Research Center The Gambia at LSHTM
Start Date
2021-05-19
Trial ID
NCT04394689
Treatments Being Tested
to assess safety and immunogenicity of measles-rubella (MR) routine immuniz...
Status
Completed
Location
Child Health Dept. Dr. Soetomo Hospital, School of Medicine Airlangga Univ.
Start Date
2017-11-16
Trial ID
NCT03680417
Treatments Being Tested
An open-label, randomized controlled, non-inferiority study of co-administr...
Status
Unknown
Location
Multiple Locations
Start Date
2023-10-14
Trial ID
NCT05771779
Treatments Being Tested
If your serious vaccine-induced adverse event has been entered in the CDC V...
Status
Unknown
Location
Neuroganics LLC
Start Date
2022-03-15
Trial ID
NCT05095844
Treatments Being Tested
The purpose of this study is to evaluate the safety, reactogenicity, and im...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2024-01-15
Trial ID
NCT06213506
The purpose of this study is to assess the immunogenicity, safety, and reac...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-05-10
Trial ID
NCT02699099
Treatments Being Tested